Course Introduction
Effective tuberculosis (TB) control depends on identifying people with TB disease promptly, ensuring access to accurate diagnosis, initiating appropriate treatment, and monitoring outcomes until the treatment episode is resolved. Despite advances in diagnostic technologies and treatment regimens, gaps in case detection, incomplete notification, delays in treatment initiation, loss to follow-up, and inconsistent outcome reporting can undermine programme effectiveness. This course equips participants with practical skills to monitor the TB care pathway, assess case detection performance, strengthen treatment outcome reporting, and use reliable programme data to improve service delivery and public health accountability.
The training examines the full TB case detection process, from identifying people with symptoms or risk factors through screening, diagnostic testing, clinical evaluation, case classification, notification, and treatment initiation. Participants will explore the roles of health facilities, laboratories, community health workers, referral networks, and private healthcare providers in identifying people who may otherwise remain undiagnosed or unreported. The course covers bacteriologically confirmed and clinically diagnosed TB, pulmonary and extrapulmonary disease, and drug-susceptible and drug-resistant TB. It emphasizes the use of current national protocols and standardized World Health Organization (WHO) surveillance definitions to support consistent recording, analysis, and reporting.
A central component focuses on selecting, calculating, and interpreting indicators for TB case detection and diagnostic performance. Participants will learn to monitor notifications, diagnostic testing coverage, laboratory turnaround times, linkage between laboratory results and treatment registers, and the proportion of diagnosed people who initiate appropriate treatment. They will examine how screening and referral activities, access to WHO-recommended rapid diagnostic tests, contact investigation, and integration with HIV services can influence case detection. The course also addresses the distinction between reported notifications and estimated disease incidence, helping participants understand why increases or decreases in notifications require careful interpretation alongside testing volume, diagnostic access, reporting completeness, and other contextual evidence.
The course develops participants’ capacity to monitor treatment outcomes using standardized cohort-based methods. Participants will examine treatment success, cure, treatment completion, death, treatment failure, and loss to follow-up according to applicable reporting definitions. They will learn how to establish treatment cohorts, determine reporting periods, reconcile patient records, review interim outcomes where appropriate, and analyse results by facility, district, age group, disease classification, HIV status where available, and drug-resistance category. Special attention is given to documenting transfers, resolving unknown outcomes, identifying treatment interruptions, and distinguishing incomplete outcome reporting from genuine clinical or programme failures.
Reliable monitoring requires strong information systems, data quality controls, and effective coordination across the care pathway. Participants will explore paper-based registers, electronic case-based surveillance systems, laboratory information systems, pharmacy records, treatment registers, and routine health information platforms. They will learn to identify duplicate notifications, missing identifiers, inconsistent dates, incomplete diagnostic results, unmatched laboratory records, and discrepancies between case notifications and treatment outcomes. The course also addresses confidentiality, appropriate access to patient information, record linkage, data validation, supportive supervision, and the responsible use of digital tools to improve completeness and timeliness without compromising patient privacy.
The final component emphasizes translating monitoring findings into corrective action and continuous programme improvement. Participants will learn to develop dashboards, cohort reports, performance scorecards, and review meetings that identify bottlenecks, highlight facilities requiring support, and guide targeted interventions. They will explore how findings can inform diagnostic service expansion, referral improvement, patient-centred treatment support, contact investigation, TB/HIV collaboration, and follow-up of people at risk of interrupting treatment. By the end of the course, participants will be better prepared to strengthen TB surveillance, improve case detection and notification, monitor treatment outcomes accurately, and support evidence-based decisions that contribute to more effective tuberculosis prevention and care.
Duration
5 days
Who Should Attend
-
National and subnational TB programme managers responsible for case detection, treatment performance, surveillance, and programme accountability.
-
Public health officers coordinating tuberculosis control activities, screening services, referral networks, and treatment monitoring.
-
Monitoring and evaluation specialists developing TB indicators, cohort reports, programme dashboards, and performance review frameworks.
-
TB surveillance officers responsible for case registration, notification completeness, reporting accuracy, and routine data analysis.
-
Clinical officers, nurses, physicians, and other qualified healthcare professionals involved in TB diagnosis, treatment initiation, and follow-up.
-
Laboratory managers and diagnostic focal persons monitoring testing coverage, result turnaround, and linkage of laboratory results to clinical care.
-
Health information officers managing TB registers, electronic surveillance platforms, routine reporting systems, and patient record reconciliation.
-
District, county, regional, and facility-level TB coordinators responsible for supervising services and addressing programme performance gaps.
-
Drug-resistant TB programme professionals monitoring diagnostic confirmation, treatment enrolment, interim progress, and final outcomes.
-
TB/HIV focal persons coordinating screening, referral, diagnosis, treatment, and collaborative monitoring for people affected by both conditions.
-
Community health programme coordinators supporting symptom identification, referral, treatment adherence support, and tracing of people who miss appointments.
-
Data analysts and statisticians conducting cohort analysis, indicator calculations, trend analysis, and data quality assessments.
-
Internal auditors and quality improvement officers reviewing compliance with reporting standards and the reliability of programme information.
-
NGO and community-based organization staff supporting TB screening, case finding, treatment support, and community-based follow-up.
-
Development partners, researchers, and health programme advisers supporting TB system strengthening, surveillance improvement, and performance evaluation.
Course Objectives
By the end of this course, participants will be able to:
-
Explain the TB care pathway and the principles of case detection, diagnostic confirmation, notification, treatment initiation, and outcome monitoring using standardized surveillance definitions.
-
Develop indicator frameworks for monitoring screening, diagnostic testing, case notification, treatment initiation, referral completion, and treatment outcomes across relevant programme levels.
-
Calculate and interpret TB notification rates, diagnostic coverage, treatment initiation measures, treatment success, and other indicators using appropriate denominators and reporting periods.
-
Assess case detection performance by reviewing screening activities, access to diagnostic services, laboratory results, reporting completeness, referral pathways, and potential undernotification.
-
Establish and analyse treatment cohorts using standardized definitions for cure, treatment completion, death, failure, loss to follow-up, and other applicable outcome categories.
-
Apply data quality assessment methods to identify duplicate records, missing information, inconsistent classifications, unmatched laboratory results, and discrepancies across reporting systems.
-
Monitor drug-resistant TB detection and treatment pathways, including drug-susceptibility testing, appropriate treatment initiation, and relevant treatment outcome indicators.
-
Examine TB/HIV collaborative monitoring and other relevant service integration indicators while protecting confidential patient information and respecting applicable reporting requirements.
-
Develop dashboards, cohort reports, and performance summaries that identify operational bottlenecks, explain data limitations, and support timely management decisions.
-
Prepare evidence-based improvement plans that assign responsibilities, strengthen case finding and follow-up, improve outcome reporting, and monitor corrective actions over time.
Comprehensive Course Outline
Module 1: Foundations of TB Case Detection and Outcome Monitoring
-
Understanding the TB care pathway and the relationship between screening, diagnosis, notification, treatment initiation, follow-up, and final outcomes.
-
Reviewing standardized case definitions, disease classifications, reporting categories, and applicable national and WHO surveillance requirements.
-
Distinguishing bacteriologically confirmed and clinically diagnosed TB, pulmonary and extrapulmonary disease, and drug-susceptible and drug-resistant TB.
-
Examining how routine surveillance indicators support programme management, resource allocation, accountability, and continuous improvement in TB services.
Module 2: TB Screening, Diagnosis, and Case Detection
-
Monitoring the identification of people with presumptive TB through health facilities, community outreach, contact investigation, and targeted screening approaches.
-
Assessing access to appropriate diagnostic testing, including WHO-recommended rapid diagnostic tests and other nationally approved diagnostic methods.
-
Tracking diagnostic turnaround times, result communication, clinical assessment, and completion of referrals from screening points to diagnostic services.
-
Identifying missed diagnostic opportunities, delays in evaluation, barriers to healthcare access, and potential gaps between estimated disease burden and notified cases.
Module 3: Case Notification, Registration, and Treatment Initiation
-
Establishing standardized procedures for recording and notifying diagnosed TB cases within the appropriate surveillance and programme reporting systems.
-
Monitoring completeness and timeliness of notification by comparing clinical registers, laboratory results, treatment records, and reporting databases.
-
Calculating and interpreting case notification indicators using clearly defined numerators, denominators, geographical units, and reporting periods.
-
Assessing linkage from diagnosis to treatment initiation and identifying delays, incomplete referrals, and cases with missing treatment start dates.
Module 4: TB Surveillance Data Sources and Information Systems
-
Reviewing the roles of TB presumptive registers, laboratory information systems, treatment registers, electronic medical records, and routine health information platforms.
-
Establishing data flow procedures between community services, diagnostic laboratories, health facilities, referral centres, and programme management teams.
-
Applying appropriate record linkage and unique identification methods to reconcile patient information and reduce duplicate notifications across reporting systems.
-
Strengthening digital and paper-based reporting workflows through standardized definitions, clear responsibilities, secure information management, and timely data submission.
Module 5: Treatment Outcome Definitions and Cohort Analysis
-
Applying standardized outcome definitions for cure, treatment completion, death, treatment failure, loss to follow-up, and not evaluated, as applicable to the treatment regimen.
-
Establishing treatment cohorts according to diagnosis or treatment registration periods and determining when outcome data should be finalized.
-
Calculating treatment success and other outcome proportions using appropriate cohort denominators and documenting incomplete or unresolved outcomes.
-
Comparing treatment outcomes across facilities, geographical areas, patient groups, and disease classifications while accounting for differences in cohort composition.
Module 6: Monitoring Treatment Continuity and Drug-Resistant TB
-
Monitoring scheduled follow-up, treatment interruptions, missed appointments, referral completion, and the recording of interim treatment progress.
-
Assessing the availability and use of patient-centred support mechanisms that help people remain engaged in treatment and access follow-up services.
-
Tracking drug-susceptibility testing, rifampicin-resistant TB identification, linkage to appropriate treatment, and relevant drug-resistant TB outcome reporting.
-
Analysing treatment continuity challenges and identifying service delivery, social, logistical, and information system factors that may contribute to unfavourable outcomes.
Module 7: TB/HIV Collaboration and Integrated Monitoring
-
Monitoring TB screening and diagnostic pathways among people living with HIV and relevant HIV service indicators among people diagnosed with TB.
-
Reviewing referral and linkage arrangements between TB clinics, HIV care services, laboratories, and other appropriate clinical services.
-
Analysing collaborative service indicators using standardized definitions and appropriate disaggregation while avoiding duplicate counting across programme systems.
-
Establishing confidentiality safeguards and coordination mechanisms that improve continuity of care and the completeness of integrated TB/HIV reporting.
Module 8: Data Quality Assurance and Performance Analysis
-
Assessing data completeness, accuracy, consistency, validity, timeliness, and concordance between source documents and reported TB indicators.
-
Detecting duplicate records, missing outcomes, inconsistent patient classifications, impossible dates, unmatched diagnostic results, and implausible reporting patterns.
-
Conducting data verification, record reconciliation, supervisory review, and structured data quality assessments to improve surveillance reliability.
-
Analysing notification trends, diagnostic coverage, treatment outcomes, reporting gaps, and differences between facilities to identify priorities for further investigation.
Module 9: Dashboards, Reporting, and Programme Review
-
Developing dashboards and scorecards that summarize case notifications, diagnostic performance, treatment initiation, cohort outcomes, and data quality indicators.
-
Preparing routine programme reports that explain performance trends, major gaps, data limitations, and actions required at facility and management levels.
-
Conducting structured review meetings with clinical teams, laboratory personnel, surveillance officers, and programme managers to validate findings.
-
Translating performance analysis into prioritized recommendations, assigned responsibilities, follow-up timelines, and mechanisms for tracking implementation progress.
Module 10: Practical Monitoring Framework and Improvement Planning
-
Analysing a sample TB dataset to calculate case detection and treatment outcome indicators and identify reporting inconsistencies.
-
Conducting a simulated cohort review to classify outcomes, identify unresolved records, and prepare a standardized performance summary.
-
Developing a practical dashboard and data quality improvement plan covering notification completeness, diagnostic linkage, treatment initiation, and outcome recording.
-
Preparing an implementation roadmap that assigns responsibilities, defines reporting schedules, strengthens supervision, and establishes regular monitoring of corrective actions.
Training Approach
This course will be delivered by our skilled trainers who have vast knowledge and experience as expert professionals in the fields. The course is taught in English and through a mix of theory, practical activities, group discussion and case studies. Course manuals and additional training materials will be provided to the participants upon completion of the training.
Tailor-Made Course
This course can also be tailor-made to meet organization requirement. For further inquiries, please contact us on: Email: training@upskilldevelopment.com Tel: +254 721 331 808
Training Venue
The training will be held at our Upskill Training Centre. We also offer training for a group (at a discount of 10% to 50%) at requested location all over the world. The Onsite course fee covers the course tuition, training materials, two break refreshments, buffet lunch, airport transfers, Upskill gift package, and guided tour.
Visa application, travel expenses, dinners, accommodation, insurance, and other personal expenses are catered by the participant
Certification
Participants will be issued with Upskill certificate upon completion of this course.
Airport Pickup and Accommodation
Airport pickup and accommodation is arranged upon request. For booking contact our Training Coordinator through Email: training@upskilldevelopment.com, +254 721 331 808
Terms of Payment:
Unless otherwise agreed between the two parties’ payment of the course fee should be done 3 working days before commencement of the training so as to enable us to prepare better.








